This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.
This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.
This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.
Patients are given a lot of fluid post-transplant, but which to choose? Catch up on the latest evidence here.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) August 4, 2023
✳️10 tweets #NephJC catch-up ✳️
One of kidney transplantation's 1st & greatest challenges is delayed graft function (DGF) - 20-30%. In postop, trembling, weak evidence shows balance could be attained, but no fluid cure
What's BEST (fluid) solution? pic.twitter.com/3ocSa4AmtV
Is intravenous fluid therapy with a balanced crystalloid solution better than saline for patients receiving a deceased donor kidney transplant? Check out the BEST-FLUID VA by NSMC Intern Anitha Swami
